1. Home /
  2. Drug Approvals

Drug Approvals

Year-End Good Tidings for 2 Promising Biotechs

Omeros Corp. and Eyenovia Inc. were the recipients of positive news this week.

UK Okays Vaccine, Stimulus Stalls, Facebook's Digital Currency, Micron Guidance

Also, Salesforce posts successful quarter and announces Slack acquisition to effectively take on Microsoft.

Moderna Stock Is Outta Sight

I think I'll just forget to put a new price target on this name for a while. All of my prior sales were mistakes.

A New Strategy as Moderna's Charts Point to Further Gains

Here's where I'd consider taking profits.

What If AstraZeneca's Covid-19 Vaccine Doesn't Work?

Governments around the world have committed to buying hundreds of millions of doses of AZD1222.

Broadening Market Performance, the Vaccine 'Put', Trading McKesson

Basically, I think we laid out enough reasons for financial markets to revolt, yet they did not.

Eli Lilly: Back From the Depths

I am flat LLY for now. Let's see how the shares behave around the technicals. Then we'll make an equity decision.

Mysterious Mnuchin, Vaccines at the Ready, Carnival Isn't Cruising, 2 Big 'W's

A look at the charts of Advanced Micro Devices and Tesla, plus a review of the 'broadening' market action from Thursday.

Biohaven Pharmaceutical Could Pull Back From Here

Take profits or raise your stop protection.

Will Moderna's Vaccine Trigger the Same Response as Pfizer's Did?

The rotational nature of this action is making for some tricky trading.